ストックスクリーナーアプリを入手
169.20
1.12%
1.87
アフターアワーズ：
170.50
1.30
+0.77%
Quest Diagnostics Inc (DGX) 最新ニュース
Is Quest Diagnostics Stock Outperforming the S&P 500? - MSN
SVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 162 shares, decreasing direct ownership by 0.77% to 20,988 units (SEC Form 4) - Quantisnow
Is Quest Diagnostics Stock Worth Holding Onto Right Now? - MSN
Nephron Research Downgrades Quest Diagnostics to Hold From Buy, $184 Price Target - Marketscreener.com
Is Quest Diagnostics Stock Outperforming The S&P 500? - Barchart
Truist maintains hold on Quest Diagnostics stock, $182 target By Investing.com - Investing.com Australia
Quest Diagnostics (DGX) and Google Cloud to Transform Healthcare Data with AI - Insider Monkey
DGX Stock Set to Benefit From New Google Cloud Partnership - MSN
Top 8 AI News Updates Investors Shouldn’t Miss - Insider Monkey
What 9 Analyst Ratings Have To Say About Quest Diagnostics - Benzinga
Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance - AlphaStreet
Baird Adjusts Price Target on Quest Diagnostics to $191 From $190, Keeps Outperform Rating - Marketscreener.com
Quest Diagnostics' (NYSE:DGX) Dividend Will Be Increased To $0.80 - Yahoo Finance
Quest Diagnostics SVP Michael Prevoznik sells $789,310 in stock - Investing.com
Quest Diagnostics SVP Michael Prevoznik sells $789,310 in stock By Investing.com - Investing.com Canada
Quest Diagnostics falls on Q1 outlook headwinds, reaffirms FY guidance - MSN
Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight - TradingView
Quest Diagnostics (DGX) Unveils Strategic Plans at Investor Day - GuruFocus.com
Quest Diagnostics stock falls on Q1 headwinds (DGX:NYSE) - Seeking Alpha
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day - Quantisnow
Quest Diagnostics projects steady growth beyond 2025 - Investing.com India
Quest Diagnostics Lowers Q1 Outlook, Reaffirms 2025 Guidance -March 19, 2025 at 08:42 am EDT - Marketscreener.com
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day – Company AnnouncementFT.com - Financial Times
Quest Diagnostics (NYSE:DGX) Leverages Google Cloud AI For Enhanced Patient Experience - Simply Wall St
Quest Diagnostics Revolutionizes Lab Testing With Google Cloud AI Partnership - StockTitan
Baird Adjusts Price Target on Quest Diagnostics to $190 From $189, Maintains Outperform Rating - Marketscreener.com
Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023 - GuruFocus.com
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX) - Barchart
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
SBI Securities Co. Ltd. Takes Position in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World
Blood Cancer Diagnostics Market Analysis Report 2025-2030, with Quest Diagnostics, Illumina, InVivoScribe, Asuragen, Danaher, Sequenta, SkylineDx, Bio-Rad Laboratories, Alercell & Sophia Genetics - Yahoo Finance
Catherine T. Doherty Sells 5,370 Shares of Quest Diagnostics Incorporated (NYSE:DGX) Stock - Defense World
Quest Diagnostics EVP Catherine Doherty sells $935,078 in stock By Investing.com - Investing.com Australia
Mutual of America Capital Management LLC Decreases Stake in Quest Diagnostics Incorporated (NYSE:DGX) - Defense World
Quest Diagnostics EVP Catherine Doherty sells $935,078 in stock - Investing.com India
Quest Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Citigroup Downgrades Quest Diagnostics (NYSE:DGX) to Neutral - Defense World
Quest Diagnostics EVP sells $125,865 in stock - Investing.com
Quest Diagnostics EVP sells $125,865 in stock By Investing.com - Investing.com South Africa
SVP, Clinical Solutions Kuppusamy Karthik covered exercise/tax liability with 2,871 shares and was granted 4,434 shares, increasing direct ownership by 14% to 13,119 units (SEC Form 4) - Quantisnow
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Quest Diagnostics Incorporated : Your health comes first -March 04, 2025 at 10:54 pm EST - Marketscreener.com
The Analyst Verdict: Quest Diagnostics In The Eyes Of 11 Experts - Benzinga
This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Citigroup Downgrades Quest Diagnostics to Neutral From Buy, Price Target is $185 -March 04, 2025 at 05:37 am EST - Marketscreener.com
Quest Diagnostics Stock Hits All-Time High at $176.53 By Investing.com - Investing.com Canada
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge? - Nasdaq
1.76%
1.18%
大文字化:
|
ボリューム (24 時間):